2556
M. Kissane et al. / Tetrahedron: Asymmetry 21 (2010) 2550–2558
gel using hexane–ethyl acetate as eluent (gradient elution 10–20%
ethyl acetate) to give the less polar minor diastereomer as a clear
oil (1.42 g, 34%) and the more polar major diastereomer as a clear
H, 4.31; N, 3.75; S, 8.58; Cl, 9.48. Found: C, 61.21; H, 4.70; N,
3.65; S, 8.54; Cl, 9.70);
max/cmꢁ1 (KBr) 2919 (CH), 1788 (CO oxa-
m
zolidinone), 1678 (CO); dH (300 MHz, CDCl3) 2.26 (1H, dd, J 13.4,
10.0, CHAHBPh), 3.00 (1H, overlapping dd, J 13.5, 3.6, CHAHBPh),
3.84–3.93 (1H, m, one of CH2O), 3.98 (1H, dd, J 9.0, 3.9, one of
CH2O), 4.21–4.30 (1H, br m, CHN), 6.80 [1H, s, ClHC(3)@], 7.04–
7.11 (2H, m, ArH), 7.22–7.37 (6H, m, ArH), 7.44–7.52 (2H, m,
ArH); dC (125 MHz, CDCl3) 37.1 (CH2, CH2Ph), 55.5 (CH, CHN),
66.6 (CH2, OCH2), 126.4, 127.4, 128.5, 129.0, 129.3, 129.4 [6 ꢃ CH,
aromatic CH or ClHC(3)@], 131.2 [C, aromatic C or C(2)S], 132.5
[CH, aromatic CH or ClHC(3)@], 134.7, 134.8 [2 ꢃ C, aromatic C or
C(2)S], 151.8 (C, CO), 164.1 (C, CO); HRMS (ES+): Exact mass Calcd
oil (1.75 g, 43%); Minor diastereomer: ½a D20
¼ þ138:5 (c 0.04,
ꢂ
CHCl3); m
max/cmꢁ1 (film) 1778 (CO oxazolidinone), 1694 (CO); dH
(300 MHz, CDCl3) 1.52 [3H, d, J 7.2, C(3)H3], 2.71 (1H, dd, A of
ABM, JAB 13.5, JAM 9.9, CHAHBPh), 3.23 (1H, dd, B of ABM, JAB 13.5,
JAM 3.3, CHAHBPh), 3.81 (1H, A of AB system, J 13.5, one of SCH2),
3.87 (1H, B of AB system, J 13.5, one of SCH2), 3.97–4.12 (2H, m,
CH2O), 4.24–4.34 (1H, m, CHN), 4.83 [1H, q, J 7.2, C(2)H], 7.12–
7.39 (10H, m, ArH); dC (75.5 MHz, CDCl3) 17.2 [CH3, C(3)H3], 34.6
(CH2, CH2Ph), 37.9 (CH2, SCH2), 39.3, 55.6 [2 ꢃ CH, C(2)H and
CHN], 66.1 (CH2, OCH2), 127.1, 127.4, 128.4, 129.0, 129.1, 129.4
(6 ꢃ CH, 6 ꢃ aromatic CH), 135.2, 137.9 (2 ꢃ C, 2 ꢃ aromatic C),
153.0 (C, CO), 172.4 (C, CO); HRMS (ES+): Exact mass Calcd for
for
C
19H17NO3SCl [M+H]+, 374.0618. Found 374.0602; 374.0
([C19H16NO3SCl+H)+, 50%).
C
20H21NO3S23Na [M+Na]+, 378.1140. Found 378.1138; m/z (ES+)
4.5. 5-(Benzylthio)-3-(1-chloro-3-phenylpropan-2-yl)-5-(dichloro-
methyl)oxazolidine-2,4-dione-one 7 and (S)-4-benzyl-3-[(E)-2-
(benzylthio)-3-chloroacryloyl]oxazolidin-2-one 6
356.2 {[(C20H21NO3S)+H+], 100%]}, 213.2 (4%), 104.9 (12%).
Major diastereomer: ½a D20
ꢂ
¼ ꢁ27:4 (c 0.04, CHCl3);
m
max/cmꢁ1
(film) 1777 (CO oxazolidinone), 1693 (CO); dH (300 MHz, CDCl3)
1.50 [3H, d, J 6.9, C(3)H3], 2.67 (1H, dd, A of ABM, JAB 13.5, JAM
9.9, CHAHBPh), 3.21 (1H, dd, B of ABM, JAB 13.5, JAM 3.3, CHAHBPh),
3.85 (1H, A of AB system, JAB 12.6, one of SCH2), 3.90 (1H, B of AB
system, JAB 12.6, one of SCH2), 4.10–4.23 (2H, m, CH2O), 4.64–
4.75 (1H, m, CHN), 4.87 (1H, q, J 6.9, C(2)H), 7.18–7.39 (10H, m,
ArH); dC (75.5 MHz, CDCl3) 16.9 [CH3, C(3)H3], 34.3 (CH2, CH2Ph),
37.5 (CH2, SCH2), 39.2, 55.2 [CH, C(2)H and CHN], 66.0 (CH2,
OCH2), 127.2, 127.4, 128.6, 129.0, 129.2, 129.5 (6 ꢃ CH, 6 ꢃ aro-
matic CH), 135.2, 137.5 (2 ꢃ C, 2 ꢃ aromatic C), 153.0 [C, CO],
172.0 [C, CO]; HRMS (ES+): Exact mass Calcd for C20H21NO3S23Na
[M+Na]+, 378.1140. Found 378.1134; m/z (ES+) 356.2
{[(C20H21NO3S)+H+], 100%]}.
Unrecrystallised N-chlorosuccinimide (2.63 g, 19.3 mmol) was
added in one portion to a solution of the sulfide (4S)-4-benzyl-3-
[2-(benzylthio)propanoyl]oxazolidin-2-one 3 (3.12 g, 8.8 mmol)
in toluene (60 mL). The flask was immediately immersed in an
oil bath at 130 °C and heating was maintained for 30 min with stir-
ring. The reaction mixture was cooled to 0 °C and the succinimide
by-product was removed by filtration. The solvent was evaporated
at reduced pressure to give the crude product as an orange oil, ratio
of 7:6 0.43:1. Following purification by column chromatography
on silica gel using hexane–ethyl acetate as eluent (gradient elution
5–40% ethyl acetate), 7 was isolated as a white solid (0.45 g, 9%);
(C20H18Cl3NO3S requires C, 52.36; H, 3.95; N, 3.05. Found: C,
For subsequent reactions, the 2 diastereomers were combined
(ratio of diastereomers 1:1.24) and the specific rotation of the mix-
52.48; H, 4.03; N, 3.00); m
max/cmꢁ1 (KBr) 3028 (CH), 2924 (CH),
1827 (CO), 1754 (CO); dH (300 MHz, CDCl3) 3.19 (1H, dd, A of
ABX, JAB 14.3, JAX 6.9, one of NCHCH2), 3.27 (1H, dd, B of ABX, JAB
14.3, JBX 9.6, one of NCHCH2), 3.73 (1H, dd, A of ABX, JAB 11.9, JAX
4.5, one of CH2Cl), 3.78 (1H, d, A of AB system, JAB 11.4, one of
SCH2), 3.83 (1H, d, B of AB system, JAB 11.4, one of SCH2), 4.08
(1H, dd, B of ABX, JAB 11.9, JBX 10.2, one of CH2Cl), 4.64–4.75
(1H, br m, CHN), 5.82 (1H, s, CHCl2), 7.14–7.36 (10H, m, ArH);
dC (75.5 MHz, CDCl3) 34.6, 35.5 (2 x CH2, NCHCH2 and SCH2), 42.4
(CH2, CH2Cl), 56.9 (CH, CHN), 70.6 (CH, CHCl2), 92.9 [C, C(5)],
127.6, 128.2, 128.9, 129.0, 129.1, 129.3 (6 ꢃ CH, 6 ꢃ aromatic
CH), 133.9, 135.0 (2 ꢃ C, 2 ꢃ aromatic C), 151.9 (C, CO), 167.8
(C, CO).
ture was recorded; ½a D20
¼ þ34:6 (c 0.5, CHCl3) (of the mixture of
ꢂ
diastereomers).
4.4. (S)-4-Benzyl-3-[(E)-3-chloro-2-(phenylthio)acryloyl] oxazoli-
din-2-one 4 and (S)-4-benzyl-3-[(Z)-3-chloro-2-(phenylthio)-
acryloyl]oxazolidin-2-one 5
Unrecrystallised N-chlorosuccinimide (4.00 g, 29.4 mmol) was
added in one portion to a solution of the sulfide (4S)-3-[2-(phenyl-
thio)propanoyl]-4-benzyloxazolidin-2-one 2 (4.56 g, 13.4 mmol) in
toluene (80 mL). The flask was immediately immersed in an oil
bath at 130 °C and heating was maintained for 15 min with stir-
ring. The reaction mixture was cooled to 0 °C and the succinimide
by-product was removed by filtration. The solvent was evaporated
at reduced pressure to give the crude product as a clear oil, ratio of
4:5 1:1.05. Following purification by column chromatography on
silica gel using hexane–ethyl acetate as eluent (gradient elution
5–40% ethyl acetate), 4 (1.42 g, 29%) was isolated as a low melting
The structure of 7 was determined by single crystal X-ray dif-
fraction on a crystalline sample of 7 recrystallised from ethanol.
Crystals of 7 are orthorhombic, space group P212121, formula
C
20H18Cl3NO3S, M = 458.76, a = 9.4675(9) Å, b = 10.1086(9) Å,
c = 21.340(2) Å, = 90.00°, b = 90.00°,
= 90.00°, U = 2042.3(3) Å3,
F(0 0 0) = 944, (Mo K
) = 0.573 mmꢁ1, R(Fo) = 0.0574, for 4406
observed reflections with I > 2
(I), wR2(F2) = 0.1525 for all 5951
unique reflections. Data in the h range 1.91–30.00° were collected
at 100 K on a Bruker Apex II Duo diffractometer using Mo K radi-
a
c
l
a
r
white solid; ½a 2D0
ꢂ
¼ þ11:1 (c 2.5, EtOH);
m
max/cmꢁ1 (film) 3063
(CH), 2922 (CH), 1790 (CO oxazolidinone), 1688 (CO); dH
(300 MHz, CDCl3) (the spectrum of this compound is very poorly
resolved in the oxazolidinone region of dH 2–5) 2.59–2.82 (1H, br
m, CHAHBPh), 3.20–3.39 (1H, br m, CHAHBPh), 4.07–4.20 (2H, m,
CH2O), 4.49–4.73 (1H, br m, CHN), 6.73 [1H, s, ClHC(3)@], 7.13–
7.64 (10H, m, ArH); dC (67.8 MHz, CDCl3) 37.5 (CH2, CH2Ph), 55.0
(CH, CHN), 66.4 (CH2, CH2O), 124.8 (C, aromatic C), 127.4, 128.1,
128.99, 129.01, 129.1, 129.26, 129.29, 129.4, 129.8, 130.9, 131.2,
134.9 [aromatic CH, aromatic C, ClHC(3) and C(2)S], 151.6 (C, CO),
161.8, 163.3 (2 ꢃ C, CO); HRMS (ES+): Exact mass Calcd for
a
ation, k = 0.71073 Å, and corrected for Lorentz and polarisation ef-
fects. The structure was solved by direct methods and refined by
full-matrix least-squares using all F2 data. The hydrogen atoms
were placed in calculated positions and allowed to ride on the par-
ent atom.
Compound 6 (1.41 g, 41%) was isolated as a white solid, mp 97–
99 °C; ½a 2D0
¼ þ63:2 (c 0.5, CHCl3); (C20H18ClNO3S requires C,
ꢂ
61.93; H, 4.68; N, 3.61; S, 8.27; Cl, 9.14. Found: C, 61.61; H, 4.58;
N, 3.62; S, 8.27; Cl, 9.38); m
max/cmꢁ1 (KBr) 3074 (CH), 2917 (CH),
C
19H17NO3SCl [M+H]+, 374.0618. Found 374.0604; 374.0
1773 (CO oxazolidinone), 1674 (CO); dH (300 MHz, CDCl3) (The
spectrum of this compound was very poorly resolved in the region
of dH 3–5) 2.77 (1H, dd, A of ABX, JAB 13.5, JAX 9.9, CHAHBPh), 3.32–
3.45 (1H, br m, CHAHBPh), 3.93 (2H, s, SCH2), 4.14–4.22 (2H, br m,
([C19H16NO3SCl+H)+, 28%).
Compound 5 (1.11 g, 22%) was isolated as a white solid, mp 97–
99 °C; ½a 2D0
¼ þ5:5 (c 2.5, DCM); (C19H16ClNO3S requires C, 61.04;
ꢂ